NO20005321L - Host-encoded protein expressed in Marek's disease (MDV) infected cells and antibodies thereto - Google Patents

Host-encoded protein expressed in Marek's disease (MDV) infected cells and antibodies thereto

Info

Publication number
NO20005321L
NO20005321L NO20005321A NO20005321A NO20005321L NO 20005321 L NO20005321 L NO 20005321L NO 20005321 A NO20005321 A NO 20005321A NO 20005321 A NO20005321 A NO 20005321A NO 20005321 L NO20005321 L NO 20005321L
Authority
NO
Norway
Prior art keywords
marek
disease
mdv
antibodies
host
Prior art date
Application number
NO20005321A
Other languages
Norwegian (no)
Other versions
NO20005321D0 (en
Inventor
Shane Campbell Burgess
Thornton Frederick Davison
Louis Joseph Norman Ross
Original Assignee
Inst Animal Health Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Animal Health Ltd filed Critical Inst Animal Health Ltd
Publication of NO20005321D0 publication Critical patent/NO20005321D0/en
Publication of NO20005321L publication Critical patent/NO20005321L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

NukJein- og aminosyre-sekvenser som koder for et anti-gen som assosieres med fjærfe-svulster, særlig fjærfe-svulster som assosieres med Mareks sykdomssvirus. Oppfinnelsen angår videre bruk av sekvensene innen medisin, særlig ved produksjon av blandinger som er nyttige ved behandling og forebygging av fjærfe-svulster.Nuclein and amino acid sequences encoding an antigen associated with poultry tumors, particularly poultry tumors associated with Marek's disease virus. The invention further relates to the use of the sequences in medicine, in particular in the production of mixtures which are useful in the treatment and prevention of poultry tumours.

NO20005321A 1998-04-29 2000-10-23 Host-encoded protein expressed in Marek's disease (MDV) infected cells and antibodies thereto NO20005321L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9809070.7A GB9809070D0 (en) 1998-04-29 1998-04-29 Biological material and uses thereof
PCT/GB1999/001238 WO1999055860A1 (en) 1998-04-29 1999-04-22 Host-encoded protein expressed on marek's disease (mdv)-infected cells and antibody thereto

Publications (2)

Publication Number Publication Date
NO20005321D0 NO20005321D0 (en) 2000-10-23
NO20005321L true NO20005321L (en) 2000-12-20

Family

ID=10831122

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005321A NO20005321L (en) 1998-04-29 2000-10-23 Host-encoded protein expressed in Marek's disease (MDV) infected cells and antibodies thereto

Country Status (8)

Country Link
EP (1) EP1073735A1 (en)
JP (1) JP2002518995A (en)
CN (1) CN1307638A (en)
AU (1) AU3618099A (en)
CA (1) CA2327178A1 (en)
GB (1) GB9809070D0 (en)
NO (1) NO20005321L (en)
WO (1) WO1999055860A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107090438B (en) * 2017-05-16 2021-01-01 中国农业科学院哈尔滨兽医研究所 Monoclonal antibody of antiserum I type MDV gI protein, hybridoma cell strain secreting antibody and application of monoclonal antibody
JP7760161B2 (en) * 2021-06-08 2025-10-27 国立研究開発法人農業・食品産業技術総合研究機構 Antibodies against Marek's disease virus Meq protein
CN114540312B (en) * 2022-03-16 2023-03-24 河南省农业科学院 A kind of preparation method and application of pp38 monoclonal antibody of serotype 1 Marek's disease virus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0837929A2 (en) * 1995-07-07 1998-04-29 Nippon Zeon Co., Ltd. Marek's disease virus genes and their use in vaccines for protection against marek's disease

Also Published As

Publication number Publication date
AU3618099A (en) 1999-11-16
CN1307638A (en) 2001-08-08
CA2327178A1 (en) 1999-11-04
EP1073735A1 (en) 2001-02-07
JP2002518995A (en) 2002-07-02
GB9809070D0 (en) 1998-06-24
WO1999055860A1 (en) 1999-11-04
WO1999055860A8 (en) 2001-10-04
NO20005321D0 (en) 2000-10-23

Similar Documents

Publication Publication Date Title
MXPA02002384A (en) Fibroblast growth factor like polypeptides.
DE69632536D1 (en) VACCINALS FOR THE RESPIRATORY SYNCYTIAL VIRUS WITH NUCLEIC ACIDS
CY1118443T1 (en) ANTI-TNF ANTIBODIES, COMPOSITIONS, METHODS AND USES
NO20013701D0 (en) HER-2 / neu fusion proteins
DE69536039D1 (en) A host cell containing a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule
WO1996010419A3 (en) Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule
DE3751751D1 (en) DNA ENCODING THE T CELL SURFACE PROTEIN T4 AND USE OF T4 FRAGMENTS IN THE TREATMENT OF AIDS
ATE411043T1 (en) PROCEDURE OF DNA VACCINATION
DE69924826T8 (en) USE OF CANCER ASSOCIATED ANTIGEN 5T4 TO IMMUNE THERAPY
WO1998014596A3 (en) Disease associated protein tyrosine phosphatases
DE60132190D1 (en) MUTATED VERSION OF ARGININE DEIMINASE
DK1025237T3 (en) Human checkpoint kinase, hCDS1, preparations and methods
EP1536006A4 (en) CANCER ANTIGENS AND THEIR USE
WO1998011234A3 (en) Human protein kinases
HUP9902150A2 (en) Recombinant adenoviral vectors for human tumour gene therapy
DE60025704D1 (en) THE GOODPASTURE ANTIGEN BINDING PROTEIN
WO2002050111A3 (en) Isolated laminin 10
DE69534633D1 (en) IMPLANT AND VECTOR FOR THE TREATMENT OF PUBLIC DISEASES
NO20005321L (en) Host-encoded protein expressed in Marek's disease (MDV) infected cells and antibodies thereto
EA200100395A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING DNA FRAGMENTS ENCODING ANTIGENIC PROTEIN COATING ANTI-ANTITROTHAL EFFECT
DE69924877D1 (en) Humanes akt-3 protein
BR0208771A (en) Isolated peptide or polypeptide and derivatives thereof, nucleic acid encoding the same, vaccine copying the same, nucleic acid encoding the same, vector comprising said nucleic acid, host cell comprising said nucleic acid, pharmaceutical composition comprising said peptide or polypeptide, method for treating or preventing cancer using said pharmaceutical composition and method for inducing or magnifying an immune response using said pharmaceutical composition
EP1584628A3 (en) Viral protein
WO2000065055A8 (en) Human transporter proteins
MX9709525A (en) Nucleic acid respiratory syncytial virus vaccines.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application